SRL Diagnostics launches fatty liver index
An algorithm based testing for Fatty Liver Disease
An algorithm based testing for Fatty Liver Disease
Plant is part of the company's CAD $30 million capital investment in the site
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
MINYM can be safely used by patients above 9 years of age.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
Subscribe To Our Newsletter & Stay Updated